Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Geyer

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
European Journal of Immunology|June 23, 2006
Immunoglobulin promotes the diversity and the function of T cellsCristina João, Brenda M Ogle, Susan Geyer
The New England Journal of Medicine|May 7, 2025
Cabozantinib in Advanced Neuroendocrine Tumors. ReplyJennifer A Chan, Susan Geyer, Jeffrey A Meyerhardt
Seminars in Oncology|March 13, 2016
The Bayesian basket design for genomic variant-driven phase II trialsRichard Simon, Susan Geyer, Jyothi Subramanian, et al.
Blood|May 31, 2024
Patients with a cardiac complete response in AL amyloidosis have survival rates similar to those of a matched general populationEli Muchtar, Susan Geyer, Giampaolo Merlini, et al.
Chinese Clinical Oncology|May 18, 2026
Advancing precision oncology through innovative and adaptive master protocol designs: statistical, operational, and regulatory perspectivesJun Yin, Susan Geyer, Qian Shi, et al.
Virchows Archiv : an International Journal of Pathology|August 24, 2012
Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapyAmber M D'Souza, Kamal S Pohar, Tahir Arif, et al.
Blood|April 4, 2014
Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTPSpero R Cataland, V Michael Holers, Susan Geyer, et al.
Journal of Neuro-Oncology|November 27, 2025
Short-course radiotherapy with or without temozolomide in elderly patients with newly diagnosed glioblastoma: a time-to-event meta-analysis of overall and progression-free survivalKwadwo Darko, Jianan Chen, Jeanette E Eckel-Passow, et al.
American Journal of Hematology|December 7, 2010
International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimensPrakash Thapaliya, Ayalew Tefferi, Animesh Pardanani, et al.
International Journal of Radiation Oncology, Biology, Physics|February 7, 2026
The Impact of Lung and Heart Radiation Dose during Preoperative Chemoradiation on Overall Survival in Esophageal Cancer - A Post Hoc Analysis of CALGB 80803 (Alliance)Eric J Lehrer, Susan Geyer, Austin Goodrich, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Immunology|June 23, 2006
Immunoglobulin promotes the diversity and the function of T cellsCristina João, Brenda M Ogle, Susan Geyer
The New England Journal of Medicine|May 7, 2025
Cabozantinib in Advanced Neuroendocrine Tumors. ReplyJennifer A Chan, Susan Geyer, Jeffrey A Meyerhardt
Seminars in Oncology|March 13, 2016
The Bayesian basket design for genomic variant-driven phase II trialsRichard Simon, Susan Geyer, Jyothi Subramanian, et al.
Blood|May 31, 2024
Patients with a cardiac complete response in AL amyloidosis have survival rates similar to those of a matched general populationEli Muchtar, Susan Geyer, Giampaolo Merlini, et al.
Chinese Clinical Oncology|May 18, 2026
Advancing precision oncology through innovative and adaptive master protocol designs: statistical, operational, and regulatory perspectivesJun Yin, Susan Geyer, Qian Shi, et al.
Virchows Archiv : an International Journal of Pathology|August 24, 2012
Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapyAmber M D'Souza, Kamal S Pohar, Tahir Arif, et al.
Blood|April 4, 2014
Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTPSpero R Cataland, V Michael Holers, Susan Geyer, et al.
Journal of Neuro-Oncology|November 27, 2025
Short-course radiotherapy with or without temozolomide in elderly patients with newly diagnosed glioblastoma: a time-to-event meta-analysis of overall and progression-free survivalKwadwo Darko, Jianan Chen, Jeanette E Eckel-Passow, et al.
American Journal of Hematology|December 7, 2010
International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimensPrakash Thapaliya, Ayalew Tefferi, Animesh Pardanani, et al.
International Journal of Radiation Oncology, Biology, Physics|February 7, 2026
The Impact of Lung and Heart Radiation Dose during Preoperative Chemoradiation on Overall Survival in Esophageal Cancer - A Post Hoc Analysis of CALGB 80803 (Alliance)Eric J Lehrer, Susan Geyer, Austin Goodrich, et al.
Pageof 12